HealthQuill covid-19 vaccines
Novavax, Inc.’s mid-stage trials on a combination of Covid-19 and influenza and a standalone influenza vaccine have been put on hold by the US regulator after a volunteer developed a serious nerve disorder.
Drugs Medical Pharma

USFDA puts on hold influenza, Covid-19 trial vaccines of Novavax

Novavax, Inc.’s mid-stage trials on a combination of Covid-19 and influenza and a standalone influenza vaccine have been put on hold by the.

Read More
BioNTech signs pact with Australia
Drugs Health Medical

Covid-19 vaccines increase life expectancy of heart patients, study

HQ Team May 13, 2024:  New research says Covid-19 vaccines given to people suffering from heart failure improve their chances of living longer.

Read More
DIOSynVax, a spin-out company of the University of Cambridge, is in its final stage of human trials of an antigen-based vaccine candidate to treat all coronaviruses.
Drugs Health Pharma

DIOSynVax to finish coronavirus vaccine trial in humans by month-end

HQ Team September 29, 2023: DIOSynVax, a spin-out company of the University of Cambridge, is in its final stage of human trials of.

Read More
The number of sequences to detect the presence of the Covid-19 viral genome, being shared with WHO, has dropped by more than 90%, and the number of countries sharing them has fallen by a third.
Drugs Health Medical Pharma

FDA committee recommends updating COVID booster shots to include new variants

"We need a periodic update. Second, it’s time to move from the current bivalent to a monovalent vaccines."

Read More